Sun Pharma shares jump over 9% after firm announces $12 billion Organon acquisitionSun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in ...
27 Apr, 2026, 10.33 AM IST
Stocks in news: LIC, Maruti Suzuki, Sun Pharma, TCS, HULIndian markets extended their gains on Friday, with analysts predicting a steady recovery towards the 24,300-24,700 zone. Several prominent...
13 Apr, 2026, 07.00 AM IST
US tariffs on metals and pharma: Which Indian stocks are safe and which aren't: Sudip BandyopadhyayIndian equity markets face policy risks from US tariffs and West Asia conflict. These issues impact metals and pharmaceutical sectors. Expe...
06 Apr, 2026, 01.24 PM IST
Sun Pharma shares in spotlight as company to sell 100% stake in Japanese armSun Pharma stated that it has entered into an agreement with Zaza Industrial Holdings K.K., Japan, to sell 100% of its shares in Sun Pharma...
01 Jan, 2025, 09.26 AM IST
Sun Pharma subsidiary partners with Aclaris Therapeutics for licensing agreementAs per the pact, Aclaris grants Sun Pharma exclusive rights to specific patents for using deuruxolitinib, Sun Pharma's JAK inhibitor, or ot...
06 Dec, 2023, 07.51 AM IST
Sun Pharma settles patent litigation with Celgene Corporation for cancer drug RevlimidDrug major Sun Pharma has reached an agreement with Celgene Corporation, to resolve the patent litigation regarding generic version of Revl...
22 Jun, 2021, 11.18 AM IST
Sun Pharma arm launches plaque psoriasis treatment drug in JapanIn a regulatory filing, Sun Pharmaceutical Industries said its "wholly-owned Japanese subsidiary has launched Ilumya Subcutaneous Injection...
23 Sep, 2020, 10.40 AM IST
NCLT rejects Sun Pharma’s plan to demerge overseas subsidiaryThe company had approached the Ahmedabad bench of NCLT for an approval to transfer investment undertakings from Sun Pharma to its Netherlan...
02 Jan, 2020, 09.54 AM IST
Got 2 queries from Sebi: Sun PharmaSun Pharma’s shares have been volatile in the last two months.
24 Jan, 2019, 10.10 AM IST
Sun Pharma replaces domestic formulations distributor with its own subsidiaryLast week, Sun Pharmaceutical asked markets regulator Sebi to look into the issues of certain entities and individuals allegedly adopting u...
22 Jan, 2019, 11.25 AM IST
Sun Pharma restructures certain business decisions to address corporate governance issuesThe company "unequivocally" denied that it had lent or stood guarantee for Suraksha Realty
22 Jan, 2019, 11.02 AM IST
Why Sun Pharma is under a cloud: Decoding Aditya Medisales linkA purported whistleblower letter has highlighted Sun Pharma's dealings with subsidiary AML.
19 Jan, 2019, 10.32 AM IST
Sun Pharma arm gets USFDA nod for epilepsy drugThe subsidiary concerned had in-licensed Elepsia XR from Sun Pharma Advanced Research Company (SPARC) in July 2016.
21 Dec, 2018, 04.36 PM IST
USFDA accepts Sun Pharma arm's ophthalmic drug applicationSun Pharma said that post the USFDA approval, OTX-101 will be commercialised in the US by Sun Ophthalmics, the branded ophthalmics division...
27 Dec, 2017, 11.50 AM IST
Sun Pharma launches generic versions of Daiichi Sankyo's high blood pressure drugs in USThese brands together recorded US sales of approximately $2.5 billion between August 31, 2015 and August 31, 2016, Sun Pharma said, citing ...
27 Oct, 2016, 12.02 PM IST
Sun Pharma divests Ohio unitIndia's largest drug maker Sun Pharma has sold its Bryan unit in Ohio to Nostrum laboratories as part of its consolidation of manufacturing...
14 Dec, 2015, 07.54 PM IST
Sun Pharma settles Novartis lawsuit over leukemia drugSun Pharmaceutical Industries Ltd said it was allowed to launch a generic version of Novartis' leukemia drug Gleevec in the US
15 May, 2014, 11.12 AM IST